Hygienic relevance and risk assessment of antimicrobial-impregnated textiles

Current Problems in Dermatology

Volumn 33, Issue , 2006, Pages 78-109

  Kramer, A ^a   Guggenbichler, P ^c   Heldt, P ^a   Junger M ^a   Ladwig, A ^a   Thierbach, H ^a   Weber, U ^b   Daeschlein, G ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HYGIENE NORD GMBH   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

HUMAN; HYGIENE; MICROBIOLOGY; REVIEW; RISK ASSESSMENT; SKIN; TEXTILE;

ANTI-INFECTIVE AGENTS; HUMANS; HYGIENE; RISK ASSESSMENT; SKIN; TEXTILES;

EID: 33750122593     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093938     Document Type: Review

References (204)

1. Aarestrup FM, Hasman H, Jensen LB, Moreno M, Herrero IA, Dominguez L, Finn M, Franklin A: Antimicrobial resistance among enterococci from pigs in three European countries. Appl Environ Microbiol 2002;68:4127-4129.
2. Agarwal K, Sharma A, Talukder G: Effects of copper on mammalian cell components. Chem Biol Interact 1989;69:1-16.
3. Al-Bahra MM: Darstellung von Chitinderivaten zur antimikrobiellen Ausrüstung von Textilien; dissertation, Rheinisch-Westfälische Technische Hochschule, Aachen, 2004.
4. Allan GG, Altman LC, Bensinger RE, Ghosh DK, Hirabayashi Y, Neogi AN, Neogi S: Fragmentation of chitosan by microfluidization process; in Zikakis JP (ed): Chitin, Chitosan and Related Enzymes. Orlando, Academic Press, 1984, pp 173-185.
5. Arnold LB Jr: Antimicrobial finishes for textiles: some practical aspects. Am Dyestuff Rep 1963;52:192-195.
6. Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M: Age at childhood infections and risk of atopy. Thorax 2002;57:379-382.
7. Barash A, Shoham Z, Borenstein R, Nebel L: Development of human embryos in the presence of a copper intrauterine device. Gynecol Obstet Invest 1990;29:203-206.
8. Barbolt TA: Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated Vicryl Plus antibacterial suture (coated polyglactin 910 suture with triclosan). Surg Infect 2002;3(suppl 1):45-54.
9. BIA (Berufsgenossenschaftliches Institut für Arbeitssicherheit): GESTIS - Stoffdatenbank: Alkylbenzyldimethylammoniumchlorid. Sankt Augustin, 1995.
10. Bianchini A, Grosell M, Gregory SM, Wood CM: Acute silver toxicity in aquatic animals is a function of sodium uptake rate. Environ Sci Technol 2002;36:1763-1766.
11. Bielmyer GK, Bell RA, Klaine SJ: Effects of ligand-bound silver on Ceriodaphnia dubia. Environ Toxicol Chem 2002;21:2204-2208.
12. Black JG, Howes D, Rutherford T: Percutaneous absorption and metabolism of Irgasan DP300. Toxicology 1975;3:33-47.
13. Bodner C, Godden D, Seaton A: Family size, childhood infections and atopic diseases. The Aberdeen WHEASE Group. Thorax 1998;53:28-32.
14. Bolton L, Oleniacz W, Constantine B, Kelliher BO, Jensen D, Means B, Rovee D: Repair and antibacterial effects of topical antiseptic agents in vivo; in Maibach HI, Lowe NJ (eds): Models in Dermatology. Basel, Karger, 1985, vol 2, pp 145-158.
15. Borkow G, Gabbay J: Putting copper into action: copper-impregnated products with potent biocidal activities. FASEB J 2004;18:1728-1730.
16. Braid JJ, Wale MC: The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in conditions simulating domestic use. J Antimicrob Chemother 2002;49:87-94.
17. Braoudaki M, Hilton AC: Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 2004;42:73-78.
18. Braoudaki M, Hilton AC: Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int J Antimicrob Agents 2005;25:31-37.
19. Brenwald NP, Fraise AP: Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 2003;55:141-144.
20. Buschmann HJ, Knittel D, Schollmeyer E: Textile Materialien mit Cyclodextrinen. Melliand Textilber 2001;5:368-370.
21. Buschmann HJ, Knittel D, Schollmeyer E: Wie funktionieren Textilien mit Cyclodextrinen? Melliand Textilber 2003;84:988-989.
22. Cantox US Inc: Absorption, distribution, metabolism, and excretion profile of triclosan and risk evaluation of triclosan for use in absorbable sutures, 2002.
23. Chambers PR: FAT 80'023/S potential tumorigenic and chronic toxicity effects in prolonged dietary administration to hamsters. Ciba Drug Master File, 1999.
24. Chen YM, Chung YC, Wang LW, Chen KT, Li SY: Antibacterial properties of chitosan in waterborne pathogen. J Environ Sci Health Part A Tox Hazard Subst Environ Eng 2002;37:71379-1390.
25. Chow AY, Hirsch GH, Buttar HS: Nephrotoxic and hepatotoxic effects of triclosan and chlorhexidine in rats. Toxicol Appl Pharmacol 1977;42:1-10.
26. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP: Cross-resistance between triclosan and antibiotics in P. aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001;45:428-432.
27. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP: High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003;31:124-127.
28. Chuanchuen R, Narasaki CT, Schweizer HP: The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol 2002;184: 5036-5044.
29. Cookson BD, Farrelly H, Stapleton P, Garvey RPJ, Price MR: Transferable resistance to triclosan in MRSA. Lancet 1991;337:1548-1549.
30. Cookson OC, Moffatt MF: Asthma: an epidemic in the absence of infections? Science 1997;275:41-42.
31. Dautremepuits C, Betoulle S, Paris-Palacios S, Vernet G: Immunology-related perturbations induced by copper and chitosan in carp (Cyprinus carpio L.). Arch Environ Contam Toxicol 2004;47:370-378.
32. Denning HJ, Sliwa S, Wilson GA: Triclosan: effects on pregnancy and post-natal development in rats. Ciba Drug Master File, 1992.
33. De Salva SJ, Kong BM, Lin YJ: Triclosan: a safety profile. Am J Dent 1989;2(spec iss):185-196.
34. De Vizio W, Davies R: Rationale for the daily use of a dentifrice containing triclosan in the maintenance of oral health. Compend Contin Educ Dent 2004;25(suppl 1):54-57.
35. Dokianakis SN, Kornaros ME, Lyberatos G: On the effect of pharmaceuticals on bacterial nitrite oxidation. Water Sci Technol 2004;50:341-346.
36. Drake JC: 1-year oral toxicity study in baboons with compound FAT 80'023/A. Ciba Drug Master File, 1975.
37. Elek SD, Conen PE: The virulence of Staphylococcus pyogenes for man: a study of problems with wound infection. Br J Exp Pathol 1957;38:573-586.
38. Engel RA, Gump WS: Antiseptics for textile purposes. Am Dyestuff Rep 1941;30:163-165.
39. Farooqi IS, Hopkin JM: Early childhood infection and atopic disorder. Thorax 1998;53:927-932.
40. Fisher NS, Hook SE: Toxicology tests with aquatic animals need to consider the trophic transfer of metals. Toxicology 2002;181-182:531-536.
41. Fraker SL, Smith GR: Direct and interactive effects of ecologically relevant concentrations of organic wastewater contaminants on Rana pipiens tadpoles. Environ Toxicol 2004;19:250-256.
42. Friedrich N, Völzke H, Schwahn C, Kramer A, Jünger M, Schäfer T, John U, Kocher T: Inverse association between periodontitis and respiratory allergies. Clin Exp Allergy 2006;36:495-502.
43. Furuichi Y, Rosling B, Volpe AR, Lindhe J: The effect of a triclosan/copolymer dentifrice on healing after non-surgical treatment of recurrent periodontitis. J Clin Peridontol 1999;26:63-66.
44. Gauger M, Mempel M, Schekatz A, Schäfer TH, Ring J, Abeck D: Silberbeschichtete Textilien reduzieren die Staphylococcus-aureus-Besiedebmg bei Patienten mit atopischem Ekzem. Dermatology 2003;207:15-21.
45. Gibbs S, Surridge H, Adamson R, Cohen B, Bentham G, Reading R: Atopic dermatitis and the hygiene hypothesis: a case-control study. Int J Epidemiol 2004:33:199-207.
46. Gilbert P, McBain A: Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. J Surg Infect 2002;3(suppl 1):S55-S63.
47. Gloor M, Becker A, Wasik B, Kniehl E: Triclosan, ein dermatologisches Lokaltherapeutikum. Hautarzt 2002;53:724-729.
48. Gocke E, King MT, Eckhardt K, Wild D: Mutagenicity of cosmetic ingredients licensed by the European Communities. Mutat Res 1981;90:91-109.
49. Goldsmith L: 90-day oral toxicity study in rats with FAT 801023H. Ciba Drug Master File, 1983.
50. Goodfellow G, Lee-Brotherton V, Daniels J, Roberts A, Nestmann E: Antibacterial resistance and triclosan. Soc Toxicol Ann Meet, Salt Lake City, 2003.
51. Goodman DG: Pathology Working Group report on triclosan chronic toxicity/carcinogenicity study in Sprague-Dawley rats. Ciba Drug Master File, 1990.
52. Han SY, Yang Y: Antimicrobial activity of wool fabric treated with curcumin. Dyes Pigment 2005;64:157-161.
53. Hanioka N, Omae E, Nishimura T, Jinno H, Onodera S, Yoda R, Ando M: Interaction of 2,4,4′-trichloro-2′-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver. Chemosphere 1996;3:265-276.
54. Hasman H, Aarestrup FM: tcrB, a gene conferring transferable copper resistance in Enterococcus faecium: occurrence, transferability, and linkage to macrolide and glycopeptide resistance. Antimicrob Agents Chemother 2002;46:1410-1416.
55. Hasman H, Aarestrup FM: Relationship between copper, glycopeptide, and macrolide resistance among Enterococcus faecium strains isolated from pigs in Denmark between 1997 and 2003. Antimicrob Agents Chemother 2005;49:454-456.
56. Hay AG, Dees PM, Sayler GS: Growth of a bacterial consortium with triclosan. FEMS Microbiol Ecol 2001;36:105-112.
57. Heath RJ, Rock CO: A triclosan-resistant bacterial enzyme. Nature 2000;406:145-146.
58. Henderson LM, Produlock RJ, Haynes P: Mouse micronucleus test on triclosan. Ciba Drug Master File, 1988a.
59. Henderson LM, Ransome SJ, Brabbs CE: An assessment of the mutagenic potential of triclosan using the mouse lymphoma TK locus assay. Ciba Drug Master File, 1988b.
60. Hidalgo E, Bartolome R, Barroso C, Moreno A, Dominguez C: Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998;11:140-151.
61. Hindson TC: Irgasan DP 300 in a deodorant. Contact Dermatitis 1975;1:328.
62. Hirano S: Chitin biotechnology applications. Biotechnol Annu Rev 1996;2:237-258.
63. Hites RF, Lopez-Avila V: Identification of organic compounds in an industrial wastewater. Anal Chem 1979;51:1452A-1456A.
64. Hogstrand C, Wood CM: Toward a better understanding of the bioavailability, physiology and toxicity of silver in fish: implications for water quality criteria. Environ Toxicol Chem 1998;17:547-561.
65. Hook SE, Fisher NS: Sublethal effects of silver in zooplankton: importance of exposure pathways and implications for toxicity testing. Environ Toxicol Chem 2001;20:568-574.
66. Hsieh CY, Tsai MH, Ryan DK, Pancorbo OC: Toxicity of the 13 priority pollutant metals to Vibrio fisheri in the Microtox chronic toxicity test. Sci Total Environ 2004;320:37-50.
67. Hundt K: Biotransformation von halogenierten Diphenylethern durch Pilze unter besonderer Berücksichtigung von Trametes versicolor, dissertation, Ernst-Moritz Arndt University, Greifswald, Math-Nat Fac, 2001.
68. Hundt K, Martin D, Hammer E, Jonas U, Kindermann MK, Schauer F: Transformation of triclosan by Trametes versicolor and Pycnoporus cinnabarinus. Appl Environ Microbiol 2000;66:4157-4160.
69. Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC: The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 2001;27:621-627.
70. Ishibashi H, Matsumura N, Hirano M, Matsuoka M, Shiratsuchi H, Ishibashi Y, Takao Y, Arizono K: Effects of triclosan on the early life stages and reproduction of medaka Oryzias latipes and induction of hepatic vitellogenin. Aquatic Toxicol 2004;67:167-179.
71. Jones E, Wilson L: Ames metabolic activation test to address the potential mutagenic effect of triclosan. Ciba Drug Master File, 1988.
72. Jünger M, Daeschlein G, Ladwig A, Nauck M, Haase H, Kramer A: Reduction of staphylococci in neurodermitic lesions after wearing of silver-impregnated textile. In preparation.
73. Kahn-Nathan J: What evidence is there to judge the effect of copper in the body? Contracept Fertil Sex (Paris) 1975;3:346.
74. Kim SK, Park PJ, Yang HP, Han SS: Subacute toxicity of chitosan oligosaccharide in Sprague-Dawley rats. Arzneimittelforschung 2001;51:769-774.
75. Kim SH, Son H, Nam G, Chi DY, Kim JH: Synthesis and in vitro antibacterial activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)amino] methyl cephalosporin derivatives. Bioorg Med Chem Lett 2000;10:1143-1145.
76. Kligman AM, Breit R: The identification of phototoxic drugs by human assay. J Invest Dermatol 1968;51:90-99.
77. Klöcker N, Rudolph P: Konservierte Nasensprays sind obsolet. Pharm Z 2000;145:40-42.
78. Knittel D, Buschmann HJ, Hipler C, Elsner P, Schollmeyer E: Funktionelle Textilien zur Hautpflege und als Therapeutikum. Akt Dermatol 2004;30:11-17.
79. Knittel D, Schollmeyer E: Chitosan und seine Derivate für die Textilveredlung, 1. Ausgangssituation. Textilveredlung 1998;33:67-71.
80. Knobelsdorf C, Mieck KP: Hygienisch wirkende Garne durch den Einsatz von Chitosanfasern. Textilveredlung 2000;7/8:10-15.
81. Kramer A: Antiseptika und Händedesinfektionsmittel; in Korting HC, Sterry W (eds): Therapeutische Verfahren in der Dermatologie - Dermatika und Kosmetika. Berlin, Blackwell Wissenschaft, 2001, pp 273-294.
82. Kramer A, Assadian O, Guggenbichler P, Heidecke CD, Jünger M, Lippert H, Schauer F: Beurteilung von Triclosan bezüglich seines Einsatzes in chirurgischem Nahtmaterial und Konsequenzen aus den Wirkstoffeigenschaften für den medizinischen und nicht medizinischen Einsatz, 2005a. www.dgkh.de
83. Kramer A, Assadian O, Schneider I, Soltau U, Pitten FA, Schwemmer J, Siegmund W, Müller G, Jäkel C: Begründung zur Einordnung Polihexanid-haltiger Wundspüllösungen als Arzneimittel. Stellungnahme zum Beitrag von K. Kaehn, Zur Einstufung von Polyhexanid-haltigen Wundspüllösungen, ZfW 2005;3:124-127.
84. ZfW 2005b;4:185-187.
85. Kramer A, Berencsi G, Weuffen W: Toxische und allergische Nebenwirkungen von Antiseptika; in Weuffen W, Berencsi G, Kramer A, Gröschel D, Kemter BP, Krasilnikow AP (eds): Handbuch der Antiseptik. Stuttgart, Fischer, 1985, vol 1/5, pp 113-210.
86. Kramer A, Daeschlein G, Kammerlander G, Andriessen A, Aspöck C, Bergemann R, Eberlein T, Gerngross H, Görtz G, Heeg P, Jünger M, Koch S, König B, Laun R, Peter RU, Roth B, Ruef C, Sellmer W, Wewalka G, Eisenbeiss W: Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik. Hyg Med 2004;29:147-157.
87. Kramer A, Mersch-Sundermann, Gerdes H, Pitten F-A, Tronnier H: Toxikologische Bewertung für die Händedesinfektion relevanter antimikrobieller Wirkstoffe; in Kampf G (eds): Hände-Hygiene im Gesundheitswesen. Berlin, Springer, 2003, pp 105-160.
88. Kraus H, Tiefenbrunner F: Stichprobenartige Überprüfung einzelner Tiroler Schwimmbäder auf das Vorkommen von Trichomonas vaginalis und von pathogenen Pilzen. Zentralbl Bakt Hyg I Abt Orig B 1975;160:286-291.
89. Lachapelle JM, Tennstedt D: Low allergenicity of triclosan: predictive testing in guinea pigs and in humans. Dermatologica 1979;158:379-383.
90. Lavolpe M, Greco LL, Kesselman D, Rodriguez E: Differential toxicity of copper, zinc, and lead during the embryonic development of Chasmagnathus granulatus (Brachyura, Varunidae). Environ Toxicol Chem 2004;23:960-967.
91. Lee JW, Nam CW, Ko SW: Antimicrobial finish of cotton fabric with chitosan oligomer. Proc 4th Asian Textile Conf, Federation of Asian Professional Textile Association, Taipei, June 1997, vol 2, pp 845-848.
92. Levy CE, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB: Molecular basis of triclosan activity. Nature 1999;398:383-384.
93. Levy SB: Antibacterial household products: cause for concern. Emerg Infect Dis 2001;7:512-515.
94. Li Q, Grandmaison EW, Goosen MFA, Dunn ET: Applications and properties of chitosan. J Bioact Compat Polym 1992;7:370-397.
95. Liaw HJ, Srinivasan VR: Expression of an Erwinia sp. gene encoding diphenyl ether cleavage in Escherichia coli and an isolated Acinetobacter strain PE7. Appl Environ Microbiol 1990;32:686-689.
96. Lim SH, Hudson SM: Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group. Carbohydr Res 2004;339:313-319.
97. Lopez-Avila V, Hites RA: Organic compounds in an industrial wastewater: their transport into sediments. Environ Sci Technol 1980;14:1382-1390.
98. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Price BB, Gilbert P: Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility. Appl Environ Microbiol 2003;69:5433-5442.
99. McMurry LM, McDermott PF, Levy SB: Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999;43:711-713.
100. McMurry LM, Oethinger M, Levy SB: Triclosan targets lipid synthesis. Nature 1998;394:531-532.
101. Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F: Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann Dermatol Vénéréol 2002;129:217-219.
102. Mal TK, Adorjan P, Corbett AL: Effect of copper on growth of an aquatic macrophyte, Elodea canadensis. Environ Pollut 2002;120:307-311.
103. Marrakchi H, Zhang YM, Rock CO: Mechanistic diversity and regulation of type II fatty acid synthesis. Biochem Soc Trans 2002;30:1050-1055.
104. Martinez EA, Moore BC, Schaumloffel J, Dasgupta N: Morphological abnormalities in Chironomus tentans exposed to cadmium- and copper-spiked sediments. Ecotoxicol Environ Saf 2003;55:204-212.
105. Marzulli FN, Maibach HI: Antimicrobials: experimental contact sensitization in man. J Soc Cosmet Chem 1973;24:399-421.
106. Mason RW, Edwards IR, Fisher LC: Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the rat. Comp Biochem Physiol C 1989;93:407-411.
107. Material Safety Data Sheet (MSDS): n-Propyl alcohol. Mallinckrodt Baker, 11/17/99. www.JTBaker.com
108. Matricardi PM: Infections preventing atopy: facts and new questions. Allergy 1997;52:879-882.
109. Matricardi PM, Bonini S: High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the hygiene hypothesis? Clin Exp Allergy 2000a;30:1506-1510.
110. Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, Bonini S: Exposure to food-borne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000b;320:412-417.
111. Meade MJ, Waddell RL, Callahan TM: Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 2001;204:45-48.
112. Merck Schuchardt: Sicherheitsdatenblatt Alkylbenzyldimethylammoniumchlorid, Ethanol, Ethylenglycolmonophenylether, 1-Propanol, 2-Propanol. February 2001. CD-ROM 2001/1D.
113. Meyer-Rohn J, Kulenkamp D: Klinik und Therapie der Dermatomykosen. Ärztl Praxis 1975;27: 108-110.
114. Mezcua M, Gomez MJ, Ferrer I, Aguera A, Hernando MD, Fernandez-Alba AR: Evidence of 2,7/2,8-dibenzodichloro-p-dioxin as a photodegradation product of triclosan in water and wastewater samples. Anal Chim Acta 2004;524:241-247.
115. Miyazaki T, Yamagashi T, Matsumoto M: Residues of 4-chloro-1-(2,4- dichlorophenoxy)-2-methoxybenzenes (triclosan methyl) in aquatic biota. Bull Environ Contam Toxicol 1984;32:227-232.
116. Morseth SL: Two-generation reproduction study in rats - FAT 80'023. Ciba Drug Master File, 1988.
117. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
118. Müller G, Kramer A, Karkour Y: Stellenwert silberbasierter Wundantiseptika. Vasomed, in press.
119. Müller G, Winkler Y, Kramer A: Antibacterial activity and endotoxin-binding capacity of Actisorb® Silver 220. J Hosp Infect 2003;53:211-214.
120. Nakashima H, Miyano N, Sawabe Y, Takatuka T: Photolysis and antimicrobial activity of hinokitiol in antimicrobial/deodorant processed textiles. Sen-I Gakkaishi 2002;58:129-134.
121. Nam CW, Kim YH, Ko SW: Blend fibers of polyacrylonitrile and water-soluble chitosan derivative prepared from sodium thiocyanate solution. J Appl Polymer Sci 2001;82:1620-1629.
122. Nishina A, Kihara H, Uchibori T, Oi T: Antimicrobial substances in 'DF-100' extracts of grapefruit seeds. Bokin Bobai 1991;19:401-404.
123. Ohe T: Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. Sci Total Environ 1996;181:1-5.
124. Orr R, Eggleston T, Shelanski M: Determination of the irritating and sensitizing properties of Kerlix® AMD antimicrobial gauze dressing on scarified human skin, 2001. http://www.kendallhq.com/catalog/ ClinicalInformation/KERLIXAMDonSkin.pdf
125. Orvos DR, Versteeg DJ, Inauen J, Capdevielle M, Rothenstein A, Cunningham V: Aquatic toxicity of triclosan. Environ Toxicol Chem 2002;21:1338-1349.
126. Pascual E, Julia MR: The role of chitosan in wool finishing. J Biotechnol 2001;89:289-296.
127. Paterson RA: 13-week oral toxicity study in rabbits. Ciba Drug Master File, 1969.
128. Paxéus N: Organic pollutants in effluents of large wastewater treatment plants in Sweden. Water Res 1996;30:1115-1122.
129. Paxéus N: Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 2004;50:253-260.
130. Payne J: From medical textile to smell-free socks. J Soc Dyers Colour 1997;113:48-50.
131. Percival SL, Bowler PG, Russell D: Bacterial resistance to silver in wound care. J Hosp Infect 2005;60:1-7.
132. Poon VK, Burd A: In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004;30:140-147.
133. Qian L, Sun G: Durable and regenerable antimicrobial textiles: synthesis and applications of 3-methylol-2,2,5,5-tetramethylimidazolidin-4-one (MTMIO). J Appl Polym Sci 2003;89:2418-2425.
134. Qian L, Sun G: Durable and regenerable antimicrobial textiles: improving efficacy and durability of biocidal functions. J Appl Polym Sci 2004;91:2588-2593.
135. Randall LP, Cooles SW, Piddock LJ, Woodward MJ: Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemother 2004;54:621-627.
136. Räuchle A: Triclosan; in Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (eds): Handbuch der Antiseptik. Antibakterielle, antifungielle und antivirale Antiseptik - Ausgewählte Wirkstoffe. Stuttgart, Fischer, 1987, vol II/3, pp 527-546.
137. Rayburn JR, Aladdin RK: Developmental toxicity of copper, chromium, and aluminum using the shrimp embryo teratogenesis assay: palaemonid with artificial seawater. Bull Environ Contam Toxicol 2003;71:481-488.
138. Reitsma AM, Rodeheaver GT: Effectiveness of a new antimicrobial gauze dressing as a bacterial barrier. 2001. http://www.kendallhq.com/catalog/ ClinicalInformation/AntimicrobialBarrier.pdf
139. Riach CG, McBride D, O'Mailly ML: Triclosan: assessment of genotoxicity in an unscheduled DNA synthesis assay using adult rat hepatocyte primary cultures. Ciba Drug Master File, 1988.
140. Ricci G, Patrizi A, Bendandi B, Menna G, Varotti E, Masi M: Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 2004;150:127-131.
141. Risbud MV, Karamuk E, Schlosser V, Mayer J: Hydrogel-coated textile scaffolds as candidate in liver tissue engineering. II. Evaluation of spheroid formation and viability of hepatocytes. J Biomater Sci Polym 2003;14:719-731.
142. Roed-Petersen J, Auken G, Hjorth N: Contact sensitivity to Irgasan DP 300. Contact Dermatitis 1975;1:293-294.
143. Romagnani S: Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992;98:279-285.
144. Rothenburger S, Spangler D, Bhende S, Burkley D: In vitro antimicrobial evaluation of coated Vicryl Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect 2002;3(suppl 1):79-88.
145. Rudolf M, Kampf G: Wirkstoffe; in Kampf G (ed): Hände-Hygiene im Gesundheitswesen. Berlin, Springer, 2003, pp 71-104.
146. Russell AD: Do biocides select for antibiotic resistance? J Pharm Pharmacol 2000;52:227-233.
147. Russell AD: Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. Symp Ser Soc Appl Microbiol 2002;31:121-135.
148. Russell AD: Whither triclosan? J Antimicrob Chemother 2003;53:693-695.
149. Russell AD, Maillard JY, Fuur JR: Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother 1998;42:2151.
150. Russell LB, Montgomery CS: Use of the mouse spot test to investigate the mutagenic potential of triclosan (Irgasan DP300). Mutat Res 1980;29:7-12.
151. Salminen K, Talja R, Vasenius H, Weckström P: The fungous flora of the sauna and the influence of certain disinfectants. Zentralbl Bakt Hyg I Abt Orig B 1974;158:552-560.
152. Sanchez P, Moreno E, Martinez JL: The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 2005;49:781-782.
153. Schäfer T: Ergebnisse einer randomisierten kontrollierten klinischen Studie zur Überprüfung der Wirksamkeit und des Tragekomforts einer silberbeschichteten Spezialtextilie bei atopischem Ekzem. In preparation.
154. Schäfer T, Staudt A, Ring J: Deutsches Instrument zur Erfassung der Lebensqualität bei Hauterkrankungen (DIELH). Hautarzt 2001;52:624-628.
155. Schauder S: Dermatologische Verträglichkeit von UV-Filtern, Duttstoffen und Konservierungsmitteln in Sonnenschutzpräparaten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsch 2001;44:471-479.
156. Schmid H, Dotti B, Keller B: 13-week oral toxicity (feeding) study with FAT 80'023/R (triclosan) in the hamster. Ciba Drug Master File, 1994.
157. Schmidt S, Fortnagel P, Wittich RM: Biodegradation and transformation of 4,4′- and 2,4-dihalodiphenyl ethers by Sphingomonas sp. strain SS33. Appl Environ Microbiol 1993;59:3931-3933.
158. Schmidt S, Wittich RM, Erdmann D, Wilkes H, Francke W, Fortnagel P: Biodegradation of diphenylether and its monohalogenated derivatives by Sphingomonas sp. strain SS3. Appl Environ Microbiol 1992;55:2744-2750.
159. Schmitt W: Wundinfektionen; in Schmitt W, Hartig W (eds): Allgemeine Chirurgie, ed 11. Leipzig, Barth, 1991, pp 556-572.
160. Schroder RE, Daly IW: A segment II teratology study in rats with Irgacare MP (C-P sample No 38328). Ciba Drug Master File, 1992.
161. Schultz A: Charakterisierung von extrazellulären Peroxidasen von Weissfäulepilzen der Gattungen Fomitiporia und Nematoloma und deren Bedeutung beim Abbau von Umweltschadstoffen; dissertation, Ernst-Moritz Arndt University, Greifswald, Math-Nat Fac, 2004.
162. Schweizer HP: Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001;202:1-7.
163. Seebacher C, Kramer A: Pilzinfektionen in öffentlichen Sporteinrichtungen. Hautspektrum 1997;2:5-6.
164. Singer H, Muller S, Tixier C, Pillonel L: Triclosan: occurrence and fate of a widely used biocide in the aquatic environment - Field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ Sci Technol 2002;36:4998-5004.
165. Sreenivasan P, Gaffar A: Antiplaque biocides and bacterial resistance: a review. J Clin Periodontol 2002;29:965-974.
166. Steinkjer B, Braathen LR: Contact dermatitis from triclosan (Irgasan DP 300). Contact Dermatitis 1988;18:243-244.
167. Storch M, Perry LC, Davidson JM, Ward JJ: A 28-day study of the coated Vicryl Plus antibacterial suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect 2002a;3(suppl 1):89-98.
168. Storch ML, Rothenburger SJ, Jacinto G: Experimental efficacy study of coated Vicryl Plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect 2004;5:281-288.
169. Storch M, Scalzo H, van Lue S, Jacinto G: Physical and functional comparison of coated Vicryl Plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl suture (coated polyglactin 910 suture). Surg Infect 2002b;3(suppl 1):65-78.
170. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259-1260.
171. Suller MT, Russell AD: Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. J Hosp Infect 1999;43:281-291.
172. Suller MT, Russell AD: Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000;46:11-18.
173. Sun G, Xu XJ, Bickett JR, Williams JF: Durable and regenerable antibacterial finishing of fabrics with a new hydantoin derivative. Ind Eng Chem Res 2001;40:1016-1021.
174. Sunderman FW, Lau TJ, Cralley LJ: Inhibitory effect of manganese on carcinogenicity of nickel subsulfide in rats. Cander Res 1974;34:92-95.
175. Takai K, Ohtsuka T, Senda Y, Nakao M, Yamamoto K, Matsuoka J, Hirai Y: Antibacterial properties of antimicrobial-finished textile products. Microbiol Immunol 2002;46:75-81.
176. Taplin D: Superficial mycoses. J Invest Dermatol 1976;67:177-181.
177. Thiemann L: Müssen moderne Textilien bei schweisstreibenden Tätigkeiten riechen und wie lässt sich dieses Problem beseitigen? 2004. http://www.baumann-online.de/ho_alois-kiessling/facharbeiten/ Schweissgeruch/Schweissgeruch.htm.
178. Thom DC, Davies JE, Santerre JP, Friedman S: The hemolytic and cytotoxic properties of a zeolite-containing root filling material in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:101-108.
179. Thomann P, Maurer T: Skin sensitizing (contact allergenic) effect in guinea pigs of FAT 80023/A. Ciba Drug Master File, 1975.
180. Thurman RB, Gerba CHP: The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. Crit Rev Environ Contr 1989;18:295-315.
181. Tokura S, Nishimura SI, Sakairi N, Nishi N: Biological activities of biodegradable polysaccharide. Macromol Symp 1996;101:389-396.
182. Tulp MTM, Sundström G, Martron LBJM, Hutzinger O: Metabolism of chlorodiphenyl ethers and Irgasa® DP 300. Xenobiotica 1979;9:65-77.
183. Ugur A, Ceylan O: Occurrence of resistance to antibiotics, metals, and plasmids in clinical strains of Staphylococcus spp. Arch Med Res 2003;34:130-136.
184. Untiedt S: Deodorantien; in Umbach W (ed): Kosmetik und Hygiene. Weinheim, Wiley VCH, 2004, pp 358-368.
185. Vao R, Salkinoja-Salonen M: Microbial transformation of polychlorinated phenoxy phenols. J Gen Appl Microbiol 1986;32:505-517.
186. Veronesi S, de Padova MP, Vanni D, Melino M: Contact dermatitis to triclosan. Contact Dermatitis 1986;15:257-258.
187. Vigo TL: Protection of textiles from biological attack; in Lewin M, Sello SB (eds): Handbook of Fiber Science and Technology - Chemical Processing of Fibers and Fabrics, Functional Finishes Part A. New York, Dekker, 1983, vol II, p 367.
188. Vincent JL: Nosocomial infections in adult intensive-care units. Lancet 2003;361:2068-2077.
189. Voets JP, Pipyn P, van Lancker P, Verstraete W: Degradation of microbicides under different environmental conditions. J Appl Bacteriol 1976;40:67-72.
190. von Woedtke T, Schluter B, Pflegel P, Lindequist U, Jülich WD: Aspects of the antimicrobial efficacy of grapefruit seed extract and its relation to preservative substances contained. Pharmazie 1999;54:452-456.
191. Wahlberg JE: Routine patch testing with Irgasan DP 300. Contact Dermatitis 1976;2:292.
192. Wallhäusser KH: Praxis der Sterilisation: Desinfektion - Konservierung, ed 5. Stuttgart, Thieme, 1995.
193. Wallhäusser KH, Fischer K: Die antimikrobielle Ausrüstung von Textilien. Textilveredlung 1970;5:3-14.
194. Weber DJ, Rutala WA: Use of metals as microbiocides in preventing infections in healthcare; in Block SS (ed): Disinfection, Sterilization, and Preservation, ed 5. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 415-430.
195. Werfel T: Staphylococcal toxin aggravates dermatitis in neurodermatitis. Krankenpfl J 2001;39:5-7.
196. Wigert H, Merka V, Cerovska M: Antimikrobielle Ausrüstung von Textilien; in Weuffen W (ed): Handbuch der Desinfektion und Sterilisation. Berlin, Volk und Gesundheit, 1974, vol III, pp 227-267.
197. Wilson BA, Smith VH, Denoyelles F, Larive CK: Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ Sci Technol 2003;37:1713-1719.
198. Wnorowski G: Dermal sensitization test - Buehler method for triclosan lot No 5.2.0211.0. Ciba Drug Master File, 1994.
199. Wong CS, Beck MH: Allergic contact dermatitis from triclosan in antibacterial handwashes. Contact Dermatitis 2001;45:307.
200. Wuhrman KG, Zobrist F: Untersuchungen über die bakterizide Wirkung von Silber in Wasser. Mitt Eidgen Anst Wasserversorg Schweiz Hydrol 1958;20:218-255.
201. Xue C, Yu G, Hirata T, Terao J, Lin H: Antioxidative activities of several marine polysaccharides evaluated in a phosphatidylcholine-liposomal suspension and organic solvents. Biosci Biotechnol Biochem 1998;62:206-209.
202. Yau ET, Green JD: 2-year oral administration to rats - FAT 80'023: final report. Ciba Drug Master File, 1996.
203. Ye C, Zou H, Peng Y, Liu X, Chen Z: Preparation of chitosan-collagen sponge and its application in wound dressing. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2004;21:259-260.
204. Zöllner H, Kramer A, Youssef P, Youssef U, Adrian V: Preliminary investigations on the biodegradability of selected microbicidal agents. Hyg Med 1995;20:401-407.